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To determine eﬀects of curcumin on N-methyl-N-nitrosourea (MNU) and saturated sodium chloride (s-NaCl)-induced gastric
cancer in rats. Male Wistar rats were divided into 5 groups: control (CO), control supplemented with 200mg/kg curcumin (CC),
MNU+s-NaCl, MNU+s-NaCl supplemented with 200mg/kg curcumin daily for the ﬁrst 3 weeks (MNU+s-NaCl+C3W), and
MNU+s-NaCl supplemented with curcumin for 20 weeks (MNU+s-NaCl+C20W). To induce stomach cancer, rats except for
CO and CC were orally treated with 100mg/kg MNU on day 0 and 14, and s-NaCl twice-a-week for the ﬁrst 3 weeks. The
experimentwasﬁnishedandratsweresacriﬁcedattheendof20weeks.CancerswerefoundinforestomachsofallratsinMNU+s-
NaCl. The expressions of phosphorylated inhibitor kappaB alpha (phospho-IκBα), 8-hydroxy-2 -deoxyguanosine (8-OHdG), and
cyclin D1 signiﬁcantly increased in MNU+s-NaCl compared with CO. Curcumin treatments for 3 and 20 weeks reduced the
cancer incidence resulting in a decrease of phospho-IκBα expression in benign tumor-bearing rats compared with MNU+s-NaCl.
Curcumin treatment for 20 weeks also decreased 8-OHdG expression in benign tumor-bearing rats compared with MNU+s-
NaCl. Curcumin can attenuate cancer via a reduction of phospho-IκBα and 8-OHdG expressions, which may play a promising
role in gastric carcinogenesis.
1.Introduction
Gastric cancer can generate in any part of the stomach.
Poorly detected, gastric cancer causes nearly one million
annualdeathsworldwide[1,2].Gastriccanceriscloselyasso-
ciated with dietary factors and Helicobacter pylori infection.
Previous studies have reported that consumption of salty
foods and N-nitroso compounds and a low intake of fresh
fruitsandvegetablesincreasestheriskofgastriccancer[3,4].
Hypertonic NaCl solutions induce gastric cancer in animal
models through the enhancement of tissue damage resulting
in cell proliferation [5]. Experimental animal models have
also provided support for the hypothesis that salt promotes
gastriccarcinogenesisinducedbyN-nitrosocarcinogen,such
as N-methyl-N-nitro-N-nitrosoguanidine (MNNG) or N-
methyl-N-nitrosourea (MNU) [6–9]. MNU, a mutagen and
genotoxic substance, is a potent inducer of cellular stress
leading to chromosomal aberrations, point mutations, cell
death, and DNA damage [10]. Other studies reported that
administration of MNU by oral gavage induced gastric can-
cer in rats and mice [11, 12]. Thus, the association between
saturated NaCl and N-nitroso carcinogen could promote
gastriccarcinogenesisinratsbyinﬂammation,mutation,and
compensatory cell proliferation.
Ar a n g eo fs t i m u l is u c ha sr e a c t i v eo x y g e ns p e c i e s( R O S )
and cytokines from inﬂammatory response can activate
inhibitorkappaBkinase(IKK)complexresultingininhibitor
kappaB (IκB) phosphorylation and proteolysis. Phosphory-
lation of IκBα elicits IκBα degradation, allowing the nuclear
translocationofnuclearfactorkappaB(NF-κB)complexand
activation of target genes that are involved in the control of
cellular proliferation and carcinogenesis such as cyclin D1
[13, 14]. The interaction of ROS with the nucleobases of the
DNA strand, such as guanine, leads to the formation of
8-hydroxy-2 -deoxyguanosine (8-OHdG) and structural
alteration in DNA. The 8-OHdG is a potential biomarker of
oxidative damage of DNA and a factor of initiation and
promotion of carcinogenesis [15]. These molecules play2 Journal of Biomedicine and Biotechnology
a pivotal role in carcinogenesis and may be targets for
therapeutic approaches.
Chemoprevention is promising as a preventive approach
for cancers. Curcumin (diferuloylmethane), a polyphenol
compound, is an active ingredient of tumeric (Curcuma
longa). Curcumin has chemopreventive properties. Impor-
tantly, curcumin is safe for humans and animals [16].
Curcumin shows beneﬁcial eﬀects in many cancers including
colorectal cancer, breast cancer, skin cancer, and oral cancer
[17]. Several signalling pathways implicated in carcinogen-
esis including NF-κB signalling have been modulated by
curcumin treatment [18]. However, data concerning the
eﬀect of curcumin on in vivo study of gastric cancer and key
proteins involved in carcinogenesis induced by MNU and
saturated NaCl (s-NaCl) have not been conﬁrmed.
Therefore, the present study aims to examine the protec-
tive eﬀect of curcumin on gastric cancer in rats induced by
MNU and s-NaCl administration. In addition, activation of
NF-κB, expressions of oxidative damage of DNA and cell
cycle regulator cyclin D1 will be investigated.
2. Methods
2.1. Experimental Design. 6-week-old male Wistar rats
(National Laboratory Animal Centre, Mahidol University,
Bangkok, Thailand) were used. All experiments and proce-
dures carried out on the animals were approved by the Ethics
Committee of the Faculty of Medicine, Chulalongkorn Uni-
versity, Bangkok, Thailand. Rats were housed in a controlled
temperature room at 25 ± 1◦C under standard conditions
(12-hdark-lightcycle).Thirtyratswererandomizedintoﬁve
groups (six rats each) as follows.
Control rats (CO) were fed citrate buﬀer, pH 4.5
(1mL/rat) orally via intragastric tube on days 0 and 14 of the
experiment. In addition, rats were fed normal saline
(1mL/rat) orally twice a week for the ﬁrst 3 weeks of the
experiment. Corn oil (2.5mL/kg) was administrated daily by
intragastric tube for 20 weeks.
Control rats supplemented with curcumin (CC) were fed
citrate buﬀer, pH 4.5 and normal saline as previously des-
cribed. 200mg/kg curcumin (95% puriﬁed curcumin, Cay-
man Chemical, MI, USA) was dissolved in corn oil and given
daily to rats by intragastric tube for 20 weeks.
MNU- and saturated NaCl-induced rats (MNU + s-
NaCl) were treated for gastric carcinogenesis by MNU
(Sigma-Aldrich, MO, USA) and s-NaCl (Merck, Germany)
according to Thong-Ngam et al. [19]. Brieﬂy, rats were fed
100mg/kg MNU (dissolved in citrate buﬀer, pH 4.5) via
intragastric tube on days 0 and 14 of the experiment. In
addition,ratswerefeds-NaCl(30%NaClsolution,1mL/rat)
orally twice weekly for the ﬁrst 3 weeks of the experiment.
Corn oil was administrated daily by intragastric tube for 20
weeks.
MNU-ands-NaCl-inducedrats,supplementedwithcur-
cumin for 3 weeks (MNU + s-NaCl + C3W), were given with
MNUands-NaClaspreviouslydescribe.The200mg/kgcur-
cumin was fed daily to rats by intragastric tube during
administration of MNU and s-NaCl for the ﬁrst 3 weeks.
MNU-ands-NaCl-inducedrats,supplementedwithcur-
cumin for 20 weeks (MNU + s-NaCl+C20W), were induced
with MNU and s-NaCl. The 200mg/kg curcumin was fed
daily to rats by intragastric tube for 20 weeks.
2.2. Stomach Tissues Preparation. After 20 weeks, all animals
were sacriﬁced by intraperitoneal injection of Thiopental
(Abbott, Italy, 120mg/kg) after overnight fasting. Then, the
stomach was excised and divided into 2 parts symmetrically
along the greater and lesser curves. One part was ﬁxed in
liquid nitrogen and kept at −80◦C for western blot analysis.
Another part was ﬁxed in 4% paraformaldehyde in phos-
phate-buﬀered saline (PBS) for histological study.
2.3. Histopathological Study. T h et i s s u ew a sﬁ x e dw i t h4 %
paraformaldehyde ﬁxed and paraﬃn embedded. Multiple
2μm-thick histological sections were stained with hemo-
toxylin and eosin (H&E). The alterations of gastric epithelial
cells and the incidence of gastric carcinogenesis were deter-
minedbyapathologist.Inaddition,thecancerincidencewas
calculated as percentage using the following formula:
Cancer incidence
= 100 ×
numbers of cancer-bearing rats
numbers of induced rats

.
(1)
2.4. Western Blot Analysis. T h et i s s u es a m p l e( 0 . 0 5 g )w a s
homogenized in 0.5mL of ice-cold lysis RIPA buﬀer (Cell
Signalling Technology Inc., MA, USA) with protease inhib-
itor (Sigma-Aldrich) and phosphatase inhibitor (Sigma-
Aldrich). The homogenate was sonicated for 15 seconds and
centrifuged at 11,000g for 10 minutes at 4◦C. The super-
natant was retained. Protein concentration was measured
with the BCA Protein Assay Kit (Thermo Scientiﬁc). The
extractedproteinsweremixedwithloadingbuﬀerandboiled
for 5min. Then, the extracted proteins (35μg/lane) were
applied to 10% sodium dodecyl sulfate polyacrylamide gel
electrophoresis. The separated proteins were transferred to
polyvinylidene ﬂuoride membrane (Pall Corporation, FL,
USA). The blotted membrane was incubated with 5% nonfat
dried milk in TBS (0.02M Tris, pH 7.6, and 0.15M NaCl) for
1 hour at room temperature. Then, the membrane was
probed with mouse monoclonal anti-phosphorylation of
inhibitor kappaB alpha (Phospho-IκBα, Ser32/36) antibody
(1:1000; Cell Signalling Technology Inc.) overnight at 4◦C.
Moreover, the membrane was also probed with anti-β-actin
antibody (sc-47778, 1:5,000; Santa Cruz Biotechnology Inc.,
CA, USA) for 1 hour at room temperature. After three-time
washing in TBS/0.01% Tween-20), the membrane was incu-
bated with goat anti-mouse IgG HRP secondary antibody
(1:4,000; Cayman Chemical) for 1 hour at room tempera-
ture. The bands of protein expression were developed with
a commercial chemiluminescence detection kit (Amersham
ECL plus western blotting system, GE Healthcare, UK). The
luminescence was exposed to ﬁlm (Fujiﬂim, Japan). Expres-
sion levels of proteins were quantiﬁed by ImageJ program
(US National Institutes of Health, Bethesda, MA, USA).Journal of Biomedicine and Biotechnology 3
Table 1: Histopathological changes of gastric mucosa in the experimental groups.
Group Normal Mucosal
congestion
Benign papillary
growth
Squamous cell carcinoma Cancer
incidence (%) Submucosal
invasion
Muscle
invasion
Serosal
invasion
CO (N = 6) 6 — — — — — 0
CC (N = 6) 6 — — — — — 0
MNU + s-NaCl (N = 6) — — — 2 3 1 100
MNU + s-NaCl + C3W
(N = 5) —— 2 2 1 — 6 0
MNU + s-NaCl + C20W
(N = 6) —1 2 3 — — 5 0
The level of phospho-IκBα (Ser32/36) expression was nor-
malized by β-actin density.
2.5. Immunohistochemistry. In this study, we used Bench-
Mark XT Instrument (Ventana, Medical System Inc., AZ,
USA). Immunostaining for 8-OHdG or cyclin D1 was per-
formed in paraﬃne m b e d d e ds e c t i o n sb yt h ef o l l o wi n gp r o c -
esses. Brieﬂy, the tissue sections were deparaﬃnized with EZ
prepTM. After that, the sections were retrieved the antigen
(8-OHdG or cyclin D1) with Sodium Chloride Sodium
Citrate pH 6.5–7.5 (SSCTM). Next, 1% Hydrogen peroxide
(H2O2, UltraViewTM Inhibitor) was used to block endoge-
nous peroxidase activity. Then, the primary antibody used
for8-OHdG(1:400;JapanInstitutefortheControlofAging,
Japan)orcyclinD1(1:200;ThermoScientiﬁc,MI,USA)was
applied and incubated at 37◦Cf o r6 0m i n u t e so r3 2m i n u t e s ,
respectively. After that, the goat anti-Mouse IgG (Ultra-
ViewTM HRP Multimer) was used as secondary antibody.
Color was developed by UltraViewTM DAB chromogen,
UltraViewTM H2O2, and UltraViewTM copper. Then, the
slides were counterstained with Hematoxylin II and Lithium
Carbonate. Under light microscope (Nikon E50i, Nikon
Corporation, Japan), immunoreactive cells of 8-OHdG and
cyclin D1 were deﬁned as those with dark-brown-stained
nuclei of gastric epithelial cells. To verify the expressions of
8-OHdG and cyclin D1 in all animals, digital images were
taken in high magniﬁcation ﬁeld (400x) from each sample
using a microscope equipped with digital camera (Nikon
Digital Sight DS-Fi1, Nikon Corporation, Japan). Tenimages
from two sections per animals were analyzed. The numbers
of dark brown stained in nuclei of epithelial cells were
countedmanuallyusingPointtoolintheIMAGE-PROPLUS
software program (version 6.1). A thousand gastric epithelial
cells were counted for each rat. The data were shown as the
percentage (%) of immunoreactive cells calculating from fol-
lowing equation:
The percentage of immunoreactive cells (%)
=

number of nuclei stained cells
number of examined cells

×100%.
(2)
2.6. Statistical Analysis. Statistical analyses were conducted
using Fisher’s exact test for incidence of gastric cancer. Phos-
pho-IκBα, 8-OHdG, and cyclin D1 results were shown as
mean ± SD and analyzed with one-way ANOVA and LSD
post hoc test. For all comparisons, a P value of less than 0.05
was considered to be statistically signiﬁcant. All the statistical
tests were performed using the computer program SPSS,
version 13.0, for Windows (SPSS Inc, Chicago, IL, USA).
3. Results
3.1. Gastric Cancer Incidence and Histopathological Studies
of MNU and s-NaCl-Associated Gastric Carcinogenesis and
Eﬀects of Curcumin. During the whole-study period, there
was only one rat death. At 3 weeks, the rat in MNU+s-
NaCl+ C3W died from aspiration after feeding. The results
of autopsy showed congestion and bleeding spots in both
lungs. There was hyperkeratosis in forestomach mucosa, but
no precancerous lesions or tumor was detected by histologi-
cal examination. 29 rats survived the 20 weeks of the study.
GastriccancerincidencewasshowninTable 1.Therewas
nosquamouscellcarcinoma(SCC)inCOandCCgroups.In
MNU + s-NaCl group, SCC was found in forestomach of all
rats (100%). SCC showed tumors scattered in the forestom-
ach. In gross view, the tumor masses were coliform-like
(Figure 1(a)). Histopathology of SCC showed dyskeratosis
and invasion of cancerous tissue through all layers of
stomach wall. The cancerous tissue invaded the submucosal
layer (Figure 1(b)), the muscle layer (Figure 1(c)), or the
serosa (Figure 1(d)). 3/5 (60%) rats in MNU + s-NaCl +
C3W developed SCC. 2 rats in this group showed tumor-like
lesions. Papillary growth or tumor-like lesion displayed
hyperproliferation of epithelial cells, hyperkeratosis, but no
invasion. These lesions were not diagnosed as cancers. In
MNU + s-NaCl + C20W group, three rats developed SCC
with submucosal invasion. The cancer incidence was 50%.
One rat did not exhibit a cancerous lesion. Another 2 rats
developed papillary growths.
3.2.CurcuminSupplementationfor3and20WeeksAttenuated
Development of Carcinogenesis Associated with Phospho-IκBα
Expression. From histopathological results (Table 1), rats in
MNU + s-NaCl + C3W and MNU + s-NaCl + C20W groups
were divided into subgroup C3W benign group (N = 2),
C3W cancer group (N = 3), C20W benign group (N = 3),
and C20W cancer group (N = 3). Results showed that the
expression of phosphorylated IκBα was not signiﬁcantly dif-
ferent between CO and CC. Compared with CO, phos-
phorylated IκBα expression in MNU + s-NaCl increased4 Journal of Biomedicine and Biotechnology
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Figure 1: Macroscopic (a) and microscopic (b–d, H&E staining, 40x) appearance of squamous cell carcinoma (SCC) in the forestomachs.
The multiple polypoid tumors developed in the stomach after MNU and saturated NaCl administration (a). SCCs in the gastric epithelium
show the invasion of cancerous tissue with dyskeratosis through submucosal layer (b), muscle layer (c), or serosa (d). Note: the arrows
indicate SCC with submucosal invasion (b), muscle-layer invasion (c), and stomach perforation (d). MM: muscularis mucosae, SM:
submucosa, and M: muscle layer.
Table 2: The results of phospho-IκBα-relative expression, 8-OHdG-immunoreactive cells (%), and cyclin D1-immunoreactive cells (%).
Parameters/Group CO (N = 6) CC (N = 6)
MNU + s-NaCl
(N = 6)
MNU + s-NaCl + C3W (N = 5) MNU + s-NaCl + C20W (N = 6)
C3W benign
(N = 2)
C3W cancer
(N = 3)
C20W benign
(N = 3)
C20W cancer
(N = 3)
Phospho-IκBα 0.51 ±0.11† 0.54 ±0.18† 0.82 ±0.18∗ 0.46 ±0.04† 0.60 ±0.29 0.51 ±0.08† 1.16 ±0.34∗∗,†
8-OHdG 44.42±3.41†† 40.39±3.53†† 53.06 ±5.96∗∗ 49.28 ± 7.43 48.06 ±3.47 44.99 ± 3.51† 47.77 ±2.55
Cyclin D1 38.58±5.37†† 42.53±6.90†† 54.91 ±7.93∗∗ 4.33 ±1.27∗ 54.92 ±3.87∗∗ 45.31 ±6.29 53.82 ±11.01∗∗
These data were presented as the mean ± SD. ∗Represented signiﬁcant diﬀerence compared with CO group (P<0.05). ∗∗Represented signiﬁcant diﬀerence
compared with CO group (P<0.01). †Represented signiﬁcant diﬀerence compared with MNU + s-NaCl group (P<0.05). ††Represented signiﬁcant
diﬀerence compared with MNU + s-NaCl group (P<0.01).
signiﬁcantly (P = 0.010). Curcumin supplementations for 3
and 20 weeks in C3W benign and C20W benign groups
signiﬁcantly declined the expression of phosphorylated IκBα
compared with MNU + s-NaCl (P = 0.028 and P = 0.031,
resp.)(Table 2).Therepresentedbandsofphospho-IκBαand
β-actin were shown in Figure 2.
3.3. Curcumin Supplementation for 20 Weeks Attenuated
Development of Carcinogenesis Associated with 8-OHdG and
Cyclin D1 Expressions. 8-OHdG and cyclin D1 expressions
were studied by immunohistochemistry and shown as
nuclei-stained cells. The average percentages of immunore-
active cells of all groups were shown in Table 2.F r o m
the results, the mean percentages of 8-OHdG and cyclin
D1-immunoreactive cells were not signiﬁcantly diﬀerent
between CO and CC. They were signiﬁcantly increased in
MNU + s-NaCl compared with CO (P = 0.002 and P =
0.000, resp.). Curcumin supplementation for 20 weeks
reduced gastric cancer incidence and signiﬁcantly decreased
8-OHdG expression in C20W benign group compared withJournal of Biomedicine and Biotechnology 5
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Figure 2: Western blot analysis of phospho-IκBα expression. Curcumin supplementation in C3W benign group declined the expression
of phosphorylated IκBα compared with MNU + s-NaCl (a), whereas the expression of phosphorylated IκBα in C3W cancer group did not
decrease (b). Curcumin supplementation for 20 weeks in C20W benign decreased the expression of phosphorylated IκBα compared with
MNU + s-NaCl (c), whereas the expression of phosphorylated IκBα in C20W cancer group did not decline (d). An antibody for β-actin was
used as an internal control.
MNU + s-NaCl (P = 0.015) (Table 2). The average percent-
age of cyclin D1 stained cells in the C20W benign group
tended to reduce, but not reach a statistically signiﬁcant level
when compared with MNU + s-NaCl (P = 0.062; Table 2).
8-OHdG was expressed primarily in gastric epithelial cells
(Figure 2(a)).Thisexpressionwasincreasedinthemucosaof
SCC in both MNU + s-NaCl and C20W cancer groups (Fig-
ures 3(b) and 3(c)). This enhanced expression was limited
to a small number of epithelial cells in C20W benign group
(Figure 3(d)).
4. Discussion
This study demonstrated that oral gavage of MNU- and s-
NaCl-induced a 100% cancer incidence in rats. The histo-
logical results showed that curcumin could attenuate the
gastric carcinogenesis induced by MNU and s-NaCl in rats.
Administration of curcumin in both MNU + s-NaCl + C3W
and MNU + s-NaCl + C20W groups showed 40% and 50%
reduction of cancer incidence, respectively. These observa-
tions indicated that early administration of curcumin (dur-
ing the ﬁrst 3 weeks of cancer induction) might prevent
the initiation of carcinogenesis. This is in agreement with
previous studies. Feeding 0.5 and 2.0% of commercial grade
curcumin in the diet during the initiation period (2 weeks
before, during, and 1 week after benzo(a)pyrene administra-
tion) reduced the number of mice with forestomach tumors
[20]. Daily feeding of 1 and 2g/mL radix curcumae extract
solution during MNNG administration for 40 weeks also
showed the reduction of tumor incidences in 10% NaCl and
MNNG-induced gastric cancer in rats [21].
Phosphorylation of IκBα could imply the activation of
NF-κB,whichplaysamajorroleincarcinogenesis[13,14].In
gastric carcinoma patients, NF-κB activation correlated with
IκBα phosphorylation and degradation [22, 23]. Our study
showed that overexpression of phosphorylated IκBα was
associated with cancer. This ﬁnding coincided with other
reports [24, 25]. Activation of NF-κBa p p e a r e dt ob eak e y
step of keratinocyte transformation into SCC in mice [24].
49% of prostate adenocarcinoma patients showed NF-κB
overexpression that correlated with advanced tumor stage
[25]. Curcumin has a chemopreventive property resulting in
suppressing NF-κB activation. Many studies conﬁrmed that
a pivotal role of curcumin is inhibiting IKK activity with
declining IκBα phosphorylation [26, 27]. Our results showed
that curcumin supplementations for 3 and 20 weeks sig-
niﬁcantly decreased phosphorylated IκBα in benign tumor-
bearing rats. Curcumin supplementation in this study pre-
vented carcinogenesis by declining IκBα phosphorylation.
8-OHdG is a potential biomarker of oxidative DNA
damage and a factor of initiation and promotion of carcino-
genesis [15]. In this study, we also showed that 8-OHdG
expression signiﬁcantly increased in the MNU + s-NaCl
group compared with CO group. This observation con-
ﬁrmed many previous results obtained from various types
of cancers in patients. The level of 8-OHdG expression is6 Journal of Biomedicine and Biotechnology
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Figure 3: Immunohistochemical staining of 8-OHdG antibodies in the representative tissue specimens (400x): CO group (a), MNU +
s-NaCl group (b), C20W cancer group (c), and C20W benign group (d). DAB stained immunoreactive cells (dark brown, arrows); nuclear
counterstaining was performed with Hematoxylin II and Bluing reagent. LP: laminar propria and MM: muscularis mucosae.
elevated in colorectal cancer [28], hepatocellular carcinoma
[29], oral SCC [30], and gastric cancer patients [31]. Con-
sidering the number of reports demonstrating a close
relation between 8-OHdG formation and carcinogenicity,
including this study, it is likely that 8-OHdG formations
might participate in carcinogen-induced forestomach SCC.
Curcumin showed a potent scavenger of reactive species
(RS), such as superoxide anion, hydroxyl radical, singlet oxy-
gen, nitric oxide, and peroxynitrite [32]. The reduction of
RS could prevent the formation of 8-OHdG. This study
demonstrated that 200mg/kg curcumin supplementations
for 3 and 20 weeks in MNU + s-NaCl-induced SCCs dimin-
ished 8-OHdG expression. In addition, 8-OHdG expression
in C20W benign group was signiﬁcantly reduced compared
to MNU + s-NaCl. These results suggested that curcumin
administration could protect carcinogenesis against forma-
tion of 8-OHdG.
Oxidative damage of DNA as well as deregulation of cell
cycle control causes cancer. This study demonstrated that
the immunoreactive cells of cyclin D1, the positive cell cycle
regulator, signiﬁcantly increased in MNU + s-NaCl com-
pared with CO. The nuclear accumulation of cyclin D1 is an
essential indicator of oncogenicity. Previous studies showed
that nuclear immunoreactivity for cyclin D1 positively
correlated with tumor cell proliferation of gastric cancer
patients [33]. Moreover, cyclin D1 overexpression occurred
in patients with oral SCC [34]. Cyclin D1 expression in the
C20W benign subgroup tended to decrease, but not reach a
statistically signiﬁcant level when compared with MNU + s-
NaCl. This study suggested that curcumin could not prevent
carcinogenesis through improvement of dysregulation of cell
cycle as shown by cyclin D1 accumulation.
5. Conclusion
MNU and s-NaCl led to increase of phosphorylated IκBα,8 -
OHdG, and cyclin D1 that are associated with forestomach
carcinogenesis. Concomitant treatment with 200mg/kg cur-
cumin during the ﬁrst three weeks or the entire study period
(20 weeks) could decrease cancer incidence to 40% and 50%,
respectively. This treatment shows a signiﬁcant reduction
of phosphorylated IκBα in benign rats. In addition, cur-
cumin treatment for 20 weeks signiﬁcantly reduces 8-OHdG
expression. Hence, administration of curcumin during the
initiation period could attenuate the incidence of cancer via
reduction of phospho-IκBα and 8-OHdG expressions.
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